一、说明会召开情况 2025 年 12 月 11 日，公司董事长兼总经理葛家成先生，董事、财务负责人 刘玉龙先生，董事会秘书迟明明女士，独立董事杨爱义先生出席本次说明会，针 对公司经营业绩及利润分配等相关情况，与广大投资者进行了沟通交流，就投资 者普遍关注的问题进行了回复。 二、投资者提出的主要问题及公司回复情况 公司就投资者在本次业绩说明会提出的主要问题及回复整理如下： 1、恒宁项目到今年已经第三年了，经过之前两年连续翻番的营收蓄力，预 计到何时会实现盈亏平衡？ 证券代码：603639 证券简称：海利尔 公告编号：2025-062 海利尔药业集团股份有限公司 关于公司 2025 年半年度暨第三季度业绩说明会召开情况的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 海利尔药业集团股份有限公司（以下简称"公司"）于 2025 年 12 月 11 日 14:00-15:00 在上海证券交易所上证路演中心，采用网络互动方式召开"海利尔 药业集团股份有限公司 2025 年半年度暨第三季度业绩说明会"。关于本次业绩 说明会的召开 ...

Core Viewpoint - The company, Hailir Pharmaceutical Group Co., Ltd., is set to hold an investor briefing on December 11, 2025, to discuss its half-year and third-quarter performance for 2025, allowing investors to engage and ask questions about the company's financial results and operational achievements [2][3]. Group 1: Meeting Details - The investor briefing will take place on December 11, 2025, from 14:00 to 15:00 [2][6]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, and it will be conducted in an interactive online format [2][4]. - Investors can submit questions from December 4, 2025, to December 10, 2025, before 16:00, either through the Roadshow Center website or via the company's email [5][6]. Group 2: Participants - Key participants in the meeting will include the company's Chairman and General Manager, Mr. Ge Jiacheng, along with the financial head, Mr. Liu Yulong, the board secretary, Ms. Chi Mingming, and independent director, Mr. Yang Aiyi [4]. Group 3: Contact Information - For inquiries, investors can contact Ms. Chi Mingming via phone at 0532-58659169 or through the company's email at hailir@hailir.cn [7]. - After the briefing, the main content and details of the meeting will be available on the Shanghai Stock Exchange Roadshow Center [7].

证券代码：603639 证券简称：海利尔 公告编号：2025-061 海利尔药业集团股份有限公司 关于召开 2025 年半年度暨第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025年12月11日 （星期四） 14:00-15:00 （一） 会议召开时间：2025 年 12 月 11 日 （星期四） 14:00-15:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 三、 参加人员 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于2025年12月04日 （星期四） 至12月10日 （星期三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 hailir@hailir.cn进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 海利尔药业集团股份有限公司 ...

Core Viewpoint - The company, Hailier (603639.SH), currently does not produce the active ingredient for four-fluoro ether pyrethroid and has no specific mosquito control formulations [1] Group 1: Product Information - The company's active ingredients, imidacloprid and acetamiprid, have certain efficacy against mosquitoes [1] - The project for producing 1,500 tons of acetamiprid annually in Qingdao Hengning is set to enter trial production in December 2024 [1] - Combined sales revenue from imidacloprid and acetamiprid is expected to account for less than 10% of the company's total revenue in 2024 [1]

Group 1 - The company has been exporting to EU countries over the past two years, and the related business is progressing steadily according to established plans [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 海利尔药业集团股份有限公司（以下简称"公司"）控股股东张爱英女士持有本公司股份为127,253,000 股，占公司总股本的37.44%，本次质押展期后，张爱英女士累计质押公司股份1,460,000股，占其持有 公司股份总数的1.15%，占公司总股本的0.43%。 登录新浪财经APP 搜索【信披】查看更多考评等级 二、股东累计质押股份情况 截至公告披露日，公司控股股东及其一致行动人累计质押股份情况如下： ■ 三、其他情况说明 张爱英女士资信状况良好，具备相应的资金偿还能力，其所质押的股份目前不存在平仓风险或被强制过 户风险，股份质押风险在可控范围内，不会导致公司的实际控制权发生变更、不会对公司日常经营和公 司治理稳定性产生影响。如后续出现风险，上述股东将采取包括但不限于补充质押、提前还款等措施加 以应对。公司将持续关注其股份质押情况及风险，并按照有关规定及时履行信息披露义务。敬请投资者 注意投资风险。 ● 截至本公告日，张爱英及其一致行动人葛尧伦、葛家成、青岛合 ...

证券日报网讯 11月11日晚间，海利尔发布公告称，公司于近日接到控股股东张爱英女士关于办理所持 股份质押展期的通知，本次质押展期股数为1，460，000股。 （文章来源：证券日报） ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603639 证券简称：海利尔 公告编号：2025-060 海利尔药业集团股份有限公司 关于控股股东股份质押展期的公告 重要内容提示： 海利尔药业集团股份有限公司（以下简称"公司"）控股股东张爱英女士 持有本公司股份为127,253,000股，占公司总股本的37.44%，本次质押展期后， 张爱英女士累计质押公司股份1,460,000股，占其持有公司股份总数的1.15%，占 公司总股本的0.43%。 截至本公告日，张爱英及其一致行动人葛尧伦、葛家成、青岛合意投资 中心（有限合伙）合计直接持有公司股份219，193，439股，占公司总股本的64.49%。 本次质押展期后，张爱英及其一致行动人葛尧伦、葛家成、青岛合意投资中心（有 限合伙）直接持有的公司股份中处于质押状态的股份累计数为1,460,000股，占 其合计所持公司股份总数的0.67%，占公司总股本的0.43%。 公司于近日接到控股股东张爱英女士关于办理所持股份质押展期的通知，具 体情况如下： 一、本次股份质押展期情况 ...

Core Insights - Hailir's stock price increased by 2.01% on November 7, reaching 13.72 CNY per share, with a total market capitalization of 4.663 billion CNY [1] - The company has seen a year-to-date stock price increase of 15.29%, but a decline of 6.22% over the past 20 days and 9.08% over the past 60 days [1] - Hailir's main business involves the production and sales of pesticide formulations and active ingredients, with 97.46% of revenue coming from pesticides [1] Financial Performance - For the period from January to September 2025, Hailir reported a revenue of 3.391 billion CNY, representing a year-on-year growth of 5.50%, and a net profit attributable to shareholders of 208 million CNY, up 6.15% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 1.255 billion CNY, with 680 million CNY distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, Hailir had 13,000 shareholders, a decrease of 14.70% from the previous period, with an average of 26,229 circulating shares per shareholder, an increase of 17.23% [2] - The top ten circulating shareholders include new entrants such as招商量化精选股票发起式A and招商成长量化选股股票A, with significant holdings [3]

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Viewpoints - The recent US-China talks have led to a potential recovery in demand, which is expected to positively impact the chemical industry [7] - The energy storage sector is driving an optimistic outlook for lithium battery demand, particularly benefiting the phosphate rock segment due to its rigid supply characteristics [7] Summary by Sections Industry Overview - The chemical industry is facing challenges due to the US-China trade disputes, but recent negotiations have shown signs of easing tensions, which may stabilize demand [7] - The global energy storage battery shipments are projected to exceed 500 GWh in 2025, representing a year-on-year growth of approximately 60% [7] Investment Recommendations - The report recommends buying shares in companies that are well-positioned in the green polyester industry, such as Wankai New Materials (301216) [3] - Companies in the pesticide formulation sector, like Runfeng Co. (301035), Guoguang Co. (002749), and Hailier (603639), are also recommended for purchase due to their lower exposure to trade disputes [3] - The report highlights potential recovery in the petrochemical and chemical sectors, suggesting investments in Sinopec (600028), Hengli Petrochemical (600346), Rongsheng Petrochemical (002493), Wanhua Chemical (600309), and Huayi Group (600623) [3]